Addex Therapeutics' Epilepsy Drug Fails Key Trial

TipRanks19:00

Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket

Shares of Koninklijke Philips N.V. (NYSE:PHG) rose sharply in today's pre-market trading after reporting first-quarter results. The company also resolved the respironics personal injury and medical mo

Benzinga17:53

Addex Therapeutics Announces Lack of Statistical Significance In ADX71149 Phase 2 Epilepsy Study

Addex Therapeutics (NASDAQ:ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced

Benzinga14:30

Addex Therapeutics Says Phase 2 Epilepsy Study Did Not Meet Primary Goal

RTTNews13:35

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Globe Newswire13:00

Top Premarket Decliners

Evotec (EVO) shares slumped 32% Wednesday premarket as the company unveiled a "priority reset" of its business following the appointment of a new CEO. Addex Therapeutics (ADXN) fell 13% following a 2.

MT NewswiresApr 24 20:01